Clinuvel is tipped to release phase III trial results for the skin disorder vitiligo – the 'Michael Jackson disease' – ... Read More The post Health Check: Can they beat it? D-Day looms for ‘Michael ...

Please provide your email address to receive an email when new articles are posted on . King pioneered the use of JAK inhibitors in dermatology, and his work revealed the broad utility of JAK ...

A model with a perfectly split two-tone complexion had recently left social media users stunned after a video of her went ...

The broker believes an impending announcement could put a rocket under this share if it is positive. The post Bell Potter says this ASX 300 share could rise 80%+ appeared first on The Motley Fool ...

Explore albinism, its causes, impacts, and the importance of empathy in understanding this genetic condition affecting humans and nature.

Michael Jackson’s changing face, from child star to global icon, remains a story of fame, illness, and speculation, and here ...

A month has gone by since the last earnings report for Incyte (INCY). Shares have lost about 1.8% in that time frame, underperforming the S&P 500. But investors have to be wondering, will the recent ...

A small case-control study linked higher Dietary Inflammatory Index scores with progressive vitiligo, suggesting that ...

After more than a decade with no new medications for chronic spontaneous urticaria, clinicians are beginning to see rapid ...

This review examines how gut keystone bacteria shape microbiome stability, disease risk, and responses to diet. It highlights ...

Incyte (Nasdaq:INCY) today reports 2024 second quarter financial results, and provides a status update on the Company's clinical development portfolio. "In the ...

We independently review everything we recommend. When you buy through our links, we may earn a commission. Learn more› By Mel Plaut Mel Plaut is a writer covering pets. They have tested hundreds of ...